Sandoz, a global leader in off-patent (generic and biosimilar) medicines, today announced that the European Commission (EC) granted marketing authorization in the European Union (EU) for a citrate-free high concentration…
NORTH CHICAGO, Ill., April 27, 2023 /PRNewswire/ — AbbVie (NYSE:ABBV) announced financial results for the first quarter ended March 31, 2023. “This year is off to an excellent start, with first-quarter revenues and…
Physicians and Patients Will Gain Access to Enhanced Laboratory Services and Advanced Diagnostic Testing BURLINGTON, N.C., May 3, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, today announced an agreement…
BURLINGTON, N.C., April 25, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the first quarter ended March 31, 2023, and updated full-year guidance. “Labcorp’s first quarter results set…
Labcorp (NYSE: LH), a leading global life sciences company, is partnering with the Conference of National Black Churches (CNBC) to address health equity gaps in colorectal cancer screening. To raise awareness and provide…
RAHWAY, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2023. “Inspired by our commitment to bring…
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced that Regional Cancer Care Associates (RCCA) entered…
Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Reata Pharmaceuticals as the sole specialty pharmacy provider for SKYCLARYSTM (omaveloxolone), the first and only…
McKesson ideaShare in Las Vegas from June 22–25, 2023. McKesson ideaShare is the nation’s premier community pharmacy annual education and networking event, hosted by McKesson, Health Mart, and Health Mart Atlas. The event returns…
Kalamazoo, Michigan, May 01, 2023 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the first quarter of 2023: First Quarter Results First Quarter Net Sales Growth Overview Reported…
First-Quarter 2023 Revenues of $18.3 Billion – Expected Decline in Comirnaty(1) Revenue Drove 26% Operational Decrease in First-Quarter 2023 Revenues – First-Quarter 2023 Revenues from Comirnaty(1) and Paxlovid of $7.1…
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Pfizer Inc. (NYSE: PFE) announced today that XTANDI® (enzalutamide) plus leuprolide significantly reduced the risk of metastasis or…